Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.690
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Anixa Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
| Market Capitalization | 87 | 98 | 172 | 143 | 49 | 78 | |
| Market Cap Growth | -4.44% | -42.82% | 20.19% | 191.52% | -37.33% | 3.28% | |
| Enterprise Value | 66 | 72 | 139 | 106 | 40 | 71 | |
| Last Close Price | 2.69 | 3.16 | 5.60 | 4.77 | 2.06 | 3.87 | |
| PS Ratio | - | 467.53 | - | 279.03 | - | 312.81 | |
| PB Ratio | 3.97 | 4.20 | 6.09 | 4.11 | 5.93 | 16.25 | |
| P/TBV Ratio | 4.88 | 4.03 | 5.91 | 4.03 | 5.59 | 14.94 | |
| EV/Sales Ratio | - | 342.38 | - | 206.32 | - | 285.22 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | |
| Asset Turnover | - | 0.01 | - | 0.02 | - | 0.04 | |
| Quick Ratio | 10.56 | 11.89 | 14.60 | 28.13 | 7.62 | 3.99 | |
| Current Ratio | 11.31 | 12.50 | 14.83 | 28.35 | 7.88 | 4.11 | |
| Return on Equity (ROE) | -55.24% | -38.51% | -43.74% | -61.02% | -154.36% | -236.47% | |
| Return on Assets (ROA) | -34.65% | -24.61% | -26.01% | -35.92% | -81.88% | -112.53% | |
| Return on Capital (ROIC) | -37.52% | -26.49% | -27.34% | -37.88% | -98.19% | -143.45% | |
| Earnings Yield | -14.28% | -9.99% | -7.92% | -9.07% | -20.44% | -14.89% | |
| FCF Yield | -9.68% | -6.32% | -3.78% | -3.46% | -12.63% | -6.29% | |
| Buyback Yield / Dilution | -2.36% | -2.00% | -6.28% | -28.57% | -12.33% | -12.29% | |
| Total Shareholder Return | -2.36% | -2.00% | -6.28% | -28.57% | -12.33% | -12.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.